Pharmaceutical Commerce - May/June 2013 - (Page 4)

Table of Contents DKSH pushes ‘market expansion services’ for life sciences in Asia Logistics and distribution are just the beginning of what it offers to deliver 24 Information Technology Better interoperability is the goal of an EHR vendor consortium CommonWell Health Alliance, led by McKesson and Cerner, wants to create a private-industry-focused, neutral forum for resolving technical issues Enabling item level serialization: Ten key steps to ensure success 3 Editorial Should personalized medicine imply compromised patient safety? Continuing problems with compounding pharmacies muddle biopharma’s future direction 6 Op-Ed The downside of pricing specialty pharmaceuticals too high Is the future of specialty pharmaceuticals doomed to follow the trajectory of the blockbuster era? Why ‘recall readiness’ should be topof-mind for every pharma exec Product recalls are a fact of life for today’s pharmaceutical distribution. Preparing for them ahead of time can be a substantial cost-saver 8 Top News Walgreens-Alliance Boots sends its business to AmerisourceBergen—and will buy a piece of the company Action could alter drug wholesaling and retailing; meanwhile, ABC divests Canadian wholesaling and contract packaging businesses BMS puts a $250-million chip on expanded biotech capabilities in Devens, MA Expansion will enable more process development and clinical trials manufacturing, add 350 employees For the first time, spend decreased for ‘traditional’ drugs among the commercially insured in 2012, says Express Scripts Annual Drug Trends report measures growth in specialty spending, nosedive in generics pricing; also, the idea of prescription ‘choice architecture’ to encourage better outcomes Mud-slinging continues between PBMs and community pharmacists Is the pharma industry an ‘innocent’ bystander? REMS program becomes a competitive ploy in branded-generic patent disputes FTC files an amicus curiae suit to support generics’ claim of anticompetitive use of REMS 10 Business/Finance A Conversation with Nitin Sahney, Omnicare Specialty Care Group Accenture characterizes the “New Normal” in pharma sales/marketing More emphasis on digital technologies and overall cost reduction are on the wish list Serialization and traceability inches closer to reality Manufacturers are committing capital dollars to packaging-line enhancements; but will the rest of the supply chain be ready by 2015? HDMA’s 2013 Distribution Management Award goes to GHX Track-and-trace, serialized-product pilot demonstrates supply chain interoperability 26 Compliance prompting packaging: ‘The light bulbs are coming on’ As improved medication adherence gains more focus in healthcare, the advantages of compliance packaging are becoming clearer MeadWestvaco wins Healthcare Compliance Package of the Year award Avive package changes pharmacydispensing practices; MWV also places with second runner-up 28 14 Brand Marketing & Communications Industry confronts healthcare’s changing oncology practices Health systems and community oncologists are fighting over a preferred position as care providers, while payers tighten purse strings Animal-health pharmaceuticals are jumping the ‘ethical channel’ Loss of sales exclusivity to big-box stores and online pet pharmacies add to veterinarians’ business woes 20 Supply Chain/ Logistics The convergence of environmental condition monitoring and supply chain visibility European Union, China finalize gooddistribution practices (GDPs) Broader quality management and more documentation of pharma logistics are the takeaways 4 Visit our website at May | June 2013 Manufacturing & Packaging Legal & Regulatory Lessons learned on bona fide service fees and fair market value—is there a “right answer”? Recent regulatory actions and court cases highlight the importance of due diligence in reporting the value of service fees when federal reimbursements are concerned. The financial consequences can be substantial Drug shortages continue to challenge health systems More compounding pharmacy recalls worsen the situation; FDA looks for new legislation Will crowd-sourced online search data become a better ‘sentinel’ for adverse event reporting? Academic study finds evidence of an early warning system in anonymized Web searches 31 Meetings and Editorial Index VOL. 8, NO. 3 Founder and Editor in Chief Nicholas Basta, 718 282 6112 Contributing Editors Lena Anthony, F.J. Quinn, Bob Sperber, Suzanne Shelley, Peggy Wright Editorial Board Jeffrey Berkowitz, Walgreens Richard Carlson, Blue Fin Group Liz Coyle, IMS Health Adam Fein, Pembroke Consulting Rich Minoff, 1 Global Partners Mark Seitz, Eli Lilly & Co. Robert Zachow, Bracco Diagnostics Advertising Sales Senior Vice President and Publisher Clifford P. Tallman, Jr., 203 831 0771 New England Vince Cavaseno, 617 232 2000 Jody Estabrook, 774 283 4528 Midwest David Gerchen, 314 878 3939 Southeast Cathy Williams, 843 410 2739, ext. 101 West Richard Ayer, 949 366 9089 Advertising Production Heidi Nelson, 203 852 6570, ext. 228 Circulation and Administration Senior Vice President and General Manager David Soskin, 203 831 0711 Reprints, Research and Custom Publishing David Soskin, 203 831 0711 Circulation Subscription Changes Jennifer Lee, 800 437 7456 Healthcare Commerce Media Corporation Pharmaceutical Commerce is published by Healthcare Commerce Media Corp. 85 Westminster Rd., Brooklyn, NY 11218. Editorial/Advertising Queries: 718 282 6112, or Copyright 2013. All rights reserved. Printed in the United States of America. Send all subscription inquiries or requests to Subscriptions, Pharmaceutical Commerce, 151 Fairchild Avenue, Plainview, NY 11808-1709, Tel: 800 437 7456. Fax: 516 908 3802 The management and editors of Pharmaceutical Commerce make every effort to publish accurate information. However, neither the management, editorial board, editors or reporters can be held liable for erroneous information. Opinions of Pharmaceutical Commerce columnists are their own, and do not necessarily represent those of employees or other contributors to Pharmaceutical Commerce.

Table of Contents for the Digital Edition of Pharmaceutical Commerce - May/June 2013

Pharmaceutical Commerce - May/June 2013
Table of Contents
Top News
Brand Marketing & Communications
Supply Chain/ Logistics
Information Technology
Manufacturing & Packaging
Legal & Regulatory
Meetings and Editorial Index

Pharmaceutical Commerce - May/June 2013